Wintermute Biomedical collaborates with Ten Carbon Chemistry to explore the potential of GS-2 in reusable food packaging with a $260,000 grant from the US Department of Agriculture.
Wintermute Biomedical's fatty acid formulation, GS-1, demonstrates anticancer activity. These findings were recently published in the International Journal of Molecular Sciences.
Testing of Wintermute’s topical antimicrobial therapy, Solexan™, at the State University of New York shows it has potent activity against Varicella Zoster Virus.